<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53">
 <label>53</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yakoub-Agha</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Chabannon</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Bader</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Basak</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Bonig</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Ciceri</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Management of adults and children undergoing chimeric antigen receptor T-cell therapy: Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)</article-title>. 
  <source>Haematologica</source> (
  <year>2020</year>) 
  <volume>105</volume>(
  <issue>2</issue>):
  <fpage>297</fpage>–
  <lpage>316</lpage>.  
  <pub-id pub-id-type="doi">10.3324/haematol.2019.229781</pub-id>
  <pub-id pub-id-type="pmid">31753925</pub-id>
 </mixed-citation>
</ref>
